PSYCHOSOCIAL screening tools can rapidly detect distress, anxiety, depression, and death anxiety in cancer care.
Psychosocial Screening Tools Show Clinical Utility
Rapid psychosocial screening may help oncology teams identify emotional and psychological concerns that can otherwise remain underrecognized during cancer care, according to a scoping review of validated measurement tools and psychometric evidence.
The review mapped available screening instruments designed to detect psychosocial problems in patients with cancer. Using Arksey and O’Malley’s scoping review framework, researchers searched PubMed, Scopus, and ScienceDirect for English language, full text, quantitative studies. Data extraction covered study characteristics, validation findings, application of screening tools, and key evidence on psychometric performance, clinical feasibility, and detection scope.
From 18,225 records identified, 11 studies met the inclusion criteria. Across these studies, 14 rapid psychosocial screening instruments were identified, including the Distress Thermometer, Hospital Anxiety and Depression Scale, Patient Health Questionnaire 2, Patient Health Questionnaire 9, Generalized Anxiety Disorder 7, Edmonton Symptom Assessment System, PROMIS Depression Short Form, Memorial Anxiety Scale for Prostate Cancer, Death and Dying Distress Scale, State Trait Anxiety Inventory State, Patient Health Questionnaire Anxiety Depression Scale, Montgomery Åsberg Depression Rating Scale Self Assessment, electronic visual analog scale, and Distress Assessment and Response Tool.
Clinical Feasibility Remains Central
The analysis generated three major themes: psychometric strength, clinical feasibility, and scope of detection. Psychometric strength covered validity and reliability, while feasibility centered on time efficiency, ease of use, and applicability across cancer populations. Scope of detection varied across instruments, with tools capturing depression and anxiety, general psychological distress, and death anxiety.
The findings suggest that several rapid psychosocial screening instruments have sufficient psychometric properties and practical value for oncology settings. For clinicians, the central challenge is not only selecting a validated tool, but choosing one that can be integrated efficiently into routine workflows without adding unnecessary burden for patients or care teams.
Psychosocial Screening Needs Better Integration
Although multiple instruments showed clinical promise, the review also highlighted a need for more comprehensive, rapid tools tailored to oncology practice. Future research should focus on identifying the most effective instruments for routine use and developing approaches that support early detection, timely referral, and more responsive psychosocial care.
For U.S. oncology teams, psychosocial screening may offer a structured route to identifying distress earlier and strengthening whole person cancer care, particularly when emotional symptoms, treatment burden, and quality of life concerns intersect.
Reference
Maryati I et al. Rapid psychosocial screening instruments for cancer patients: a scoping review of measurement tools and psychometric evidence. Asian Pac J Cancer Prev. 2026;27(6):1985-1995.
Featured Image: Viacheslav Yakobchuk on Adobe Stock.
- Author:
